biotech · Coronary Artery Disease
Medtronic Trading NL
Medtronic BioPharma B.V.
Medtronic BioPharma is a biotech organization headquartered in EU. Primary therapeutic focus areas include Coronary Artery Disease. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to
Company details
- Status
- Public
- HQ
- NL
- Employees
- 9
- Programs
- 1
- Drugs
- 0
- Patents
- 0
Quick answer
Medtronic BioPharma is a biotech organization headquartered in EU. Primary therapeutic focus areas include Coronary Artery Disease. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 2 (1).
Company snapshot
Medtronic Trading NL B.V. is a medical devices company based out of EINDHOVEN, Netherlands.
- 1 active pipeline program(s) linked via ClinicalTrials.gov.
- 1 trial update(s) in the last 12 months.
Public regulatory, clinical, patent, and corporate records for Medtronic Trading NL. Not investment advice.
Top assets
Lead pipeline drugs
- Phase 2
Active clinical programs
- Phase 2
Momentum signals
Momentum
Proprietary activity score for Medtronic Trading NL.
1 active signal
Signal breakdown
- Clinical trials
- Nova articles
- Patents filed
- FDA actions
- SEC filings
- Conference presentations
- Pipeline advances
Competitive landscape
Recent activity
Recent activity
Latest pipeline, patent, and corporate events for Medtronic Trading NL.
- Clinical update
Quick answers
Common questions about this sponsor — for analysts and search.
-
What is Medtronic Trading NL?
-
Is Medtronic Trading NL publicly traded?
-
What drugs does Medtronic Trading NL develop or market?
-
What are the latest developments for Medtronic Trading NL?
-
What therapeutic areas does Medtronic Trading NL focus on?
Therapeutic focus
Therapeutic area distribution
Pipeline concentration by therapeutic area from linked clinical programs.